Meet Cryosa. We are developing breakthrough, innovative technologies to solve the root cause of obstructive sleep apnea.Contact Us
The future of OSA treatment starts here.
Obstructive sleep apnea (OSA) affects millions of people worldwide, and yet none of today’s treatment options target the root cause. Plus, they’re typically invasive, require high patient compliance, or are simply ineffective. That’s why Cryosa is working to deliver the least invasive, single-treatment therapy for OSA.
Americans suffer from moderate to severe sleep apnea disorder, resulting in sleep-related medical issues as well as increases in morbidity and mortality.
Lancet Respiratory Medical (August 2019)
Experience + Success. Cryosa is led by an experienced medical device team of successful startup entrepreneurs and large med-tech engineers and professionals. Together, we’re paving a new way to solve obstructive sleep apnea.*Meet Our Team
Cryosa Closes $21.5 Million Series B Funding Round to Advance Minimally Invasive Obstructive Sleep Apnea TreatmentRead More